Skip to content

Randomized control study for exploring efficacy and safety of CART BP pro for blood pressure control in Korean hypertensive patients

Randomized control study for exploring efficacy and safety of CART BP pro for blood pressure control in Korean hypertensive patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0010769
Enrollment
400
Registered
2025-07-16
Start date
2025-10-22
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : This study is a randomized clinical trial comparing two intervention strategies in Korean patients with uncontrolled hypertension. All participants receive antihypertensive treatment

Sponsors

Korea University Anam Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ?. 19 years of age or older ?. Systolic blood pressure in the pressure chamber = 140 mmHg or starting blood pressure = 90 mmHg ?. It is expected that a new or existing book will need to be adjusted. ?. Participating in the study and participating in visits and follow-up observations during the study period

Exclusion criteria

Exclusion criteria: ?. Patients with a history of adverse reactions to the main drugs to be used in this study, such as Olmesartan, amlodipine, and hydrochlorothiazide ?. Patients suspected of secondary hypertension ?. Patients with atrial fibrillation ?. Pregnant or lactating women ?. Patients with other serious internal diseases, etc. that may make it difficult to participate in the study or interfere with the study

Design outcomes

Secondary

MeasureTime frame
1) Target blood pressure achievement rate;2) mean blood pressure

Primary

MeasureTime frame
1) Treatment emergent adverse event;2) 24 hours blood pressure load

Countries

Korea, Republic of

Contacts

Public ContactLim hyun soo

Korea University Anam Hospital

hslim1999@gmail.com+82-2-920-6022

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026